BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9889406)

  • 1. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
    Giandomenico V; Vaccari G; Fiorucci G; Percario Z; Vannuchi S; Matarrese P; Malorni W; Romeo G; Affabris GR
    Eur Cytokine Netw; 1998 Dec; 9(4):619-31. PubMed ID: 9889406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
    Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
    Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways.
    Giandomenico V; Lancillotti F; Fiorucci G; Percario ZA; Rivabene R; Malorni W; Affabris E; Romeo G
    Cell Growth Differ; 1997 Jan; 8(1):91-100. PubMed ID: 8993838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
    Sancéau J; Hiscott J; Delattre O; Wietzerbin J
    Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells.
    Arany I; Whitehead WE; Ember IA; Tyring SK
    Anticancer Res; 2003; 23(1A):495-7. PubMed ID: 12680256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid is able to induce interferon regulatory factor 1 in squamous carcinoma cells via a STAT-1 independent signalling pathway.
    Percario ZA; Giandomenico V; Fiorucci G; Chiantore MV; Vannucchi S; Hiscott J; Affabris E; Romeo G
    Cell Growth Differ; 1999 Apr; 10(4):263-70. PubMed ID: 10319996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CDK2, CDK4 and cyclin E and increased expression of p27Kip1 during treatment with interferon-alpha in carcinoid tumor cells.
    Zhou Y; Wang S; Gobl A; Oberg K
    J Biol Regul Homeost Agents; 1999; 13(4):207-15. PubMed ID: 10703944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
    Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
    Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines.
    Yokoyama M; Nakao Y; Iwasaka T; Pater A; Sugimori H
    Obstet Gynecol; 2001 Aug; 98(2):332-40. PubMed ID: 11506854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of retinoic acid and interferon alpha-2a on transitional cell carcinoma of bladder.
    Zou C; Ramakumar S; Qian L; Zou C; Zang R; Wang J; Grossman HB; Lotan R; Liebert M
    J Urol; 2005 Jan; 173(1):247-51. PubMed ID: 15592090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53.
    Um SJ; Kim EJ; Hwang ES; Kim SJ; Namkoong SE; Park JS
    Int J Cancer; 2000 Feb; 85(3):416-23. PubMed ID: 10652435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2.
    Coccia EM; Del Russo N; Stellacci E; Orsatti R; Benedetti E; Marziali G; Hiscott J; Battistini A
    Oncogene; 1999 Mar; 18(12):2129-37. PubMed ID: 10321737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis.
    Hobeika AC; Etienne W; Torres BA; Johnson HM; Subramaniam PS
    J Interferon Cytokine Res; 1999 Dec; 19(12):1351-61. PubMed ID: 10638704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ; Borden EC; Kalvakolanu DV
    Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of human acute promyelocytic leukemia NB-4 cells by interferons and all-trans retinoic acid: trans-modulation of inducible gene expression pathways.
    Kumar R; Korutla L
    Anticancer Res; 1995; 15(2):353-60. PubMed ID: 7763006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
    Crowe DL; Shuler CF
    Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells.
    Arany I; Whitehead WE; Grattendick KJ; Ember IA; Tyring SK
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):1102-6. PubMed ID: 12204966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of interferon regulatory factors 2'-5' oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness.
    Fischer T; Aman J; van der Kuip H; Rudolf G; Peschel C; Aulitzky WE; Huber C
    Br J Haematol; 1996 Mar; 92(3):595-603. PubMed ID: 8616023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines.
    Sangfelt O; Erickson S; Einhorn S; Grandér D
    Oncogene; 1997 Jan; 14(4):415-23. PubMed ID: 9053838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.